<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Parkinson hastalığı &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/parkinson-hastaligi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jan 2026 05:21:17 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Parkinson hastalığı &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Peptide Protects Dopaminergic Neurons in Parkinson’s Model</title>
		<link>https://bioengineer.org/peptide-protects-dopaminergic-neurons-in-parkinsons-model/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jan 2026 05:21:17 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Dopaminerjik nöronlar]]></category>
		<category><![CDATA[Nöroinflamasyon]]></category>
		<category><![CDATA[nörokoruma]]></category>
		<category><![CDATA[Osmotin peptidi]]></category>
		<category><![CDATA[Parkinson hastalığı]]></category>
		<guid isPermaLink="false">https://bioengineer.org/peptide-protects-dopaminergic-neurons-in-parkinsons-model/</guid>

					<description><![CDATA[In recent years, neurological disorders, particularly Parkinson’s disease (PD), have captured the attention of researchers aiming to uncover novel therapeutic strategies that can mitigate the progression of these debilitating conditions. Notably, a recent study led by an innovative team of scientists sheds light on the beneficial properties of an osmotin-derived 9-amino-acid peptide. This groundbreaking research [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320921</post-id>	</item>
		<item>
		<title>Biological Aging Forecasts Parkinson’s Patient Mortality</title>
		<link>https://bioengineer.org/biological-aging-forecasts-parkinsons-patient-mortality/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jan 2026 13:04:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biyolojik yaşlanma belirteçleri]]></category>
		<category><![CDATA[biyolojik yaşlanmanın ölçülmesi ve önemi. 2.]]></category>
		<category><![CDATA[epigenetik saat]]></category>
		<category><![CDATA[İşte 5 adet uygun Türkçe etiket: **Biyolojik yaşlanma]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket: **Parkinson mortalite tahmini]]></category>
		<category><![CDATA[mortalite tahmini]]></category>
		<category><![CDATA[Parkinson hastalığı]]></category>
		<category><![CDATA[Parkinson prognozu** * **Parkinson mortalite tahmini:** Çalışmanın temel amacı ve bulgusu (mortaliteyi tahmin etme). * **Biyol]]></category>
		<category><![CDATA[UK Biobank Parkinson çalışması]]></category>
		<category><![CDATA[UK Biobank** **Açıklama:** 1. **Biyolojik yaşlanma:** Makalenin ana konusu]]></category>
		<guid isPermaLink="false">https://bioengineer.org/biological-aging-forecasts-parkinsons-patient-mortality/</guid>

					<description><![CDATA[In a groundbreaking study poised to reshape our understanding of Parkinson’s disease prognosis, researchers have unveiled compelling evidence linking biological aging markers directly to mortality rates among Parkinson’s patients. Drawing on the expansive dataset of the UK Biobank, this research elucidates how the biological clock ticks differentially in individuals afflicted with Parkinson’s, offering a novel [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319288</post-id>	</item>
		<item>
		<title>Spatial Multiomics Uncovers Immune Dysfunction in Parkinson’s, IBD</title>
		<link>https://bioengineer.org/spatial-multiomics-uncovers-immune-dysfunction-in-parkinsons-ibd/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jan 2026 09:37:34 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bağışıklık Disfonksiyonu]]></category>
		<category><![CDATA[Cellular mechanisms** **Kısa açıklama:** 1. **Spatial multiomics:** Çalışmanın kullandığı temel ve yenilikçi teknolojiyi doğrudan vurgular. 2. **Immune dysfunction:** Araştırmanın]]></category>
		<category><![CDATA[Immune dysfunction]]></category>
		<category><![CDATA[İnflamatuar bağırsak hastalığı]]></category>
		<category><![CDATA[inflammatory bowel disease]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **Uzamsal Tek Hücre Çok-omik]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket: **Spatial multiomics]]></category>
		<category><![CDATA[Parkinson hastalığı]]></category>
		<category><![CDATA[Parkinson’s disease]]></category>
		<category><![CDATA[Periferik İmmün Sistem** * **Uzamsal Tek Hücre Çok-omik:** Çalışmanın kullandığı ana teknolojik]]></category>
		<guid isPermaLink="false">https://bioengineer.org/spatial-multiomics-uncovers-immune-dysfunction-in-parkinsons-ibd/</guid>

					<description><![CDATA[The burgeoning field of spatial single-cell multiomics is revolutionizing our understanding of complex diseases by allowing researchers to examine cellular heterogeneity within tissues with unprecedented resolution. A recent groundbreaking study published in npj Parkinson’s Disease has leveraged these advanced techniques to uncover striking insights into peripheral immune dysfunction in Parkinson’s disease (PD) and inflammatory bowel [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317446</post-id>	</item>
		<item>
		<title>Delphinidin Eases Neuroinflammation, Behavior in Parkinson’s Mice</title>
		<link>https://bioengineer.org/delphinidin-eases-neuroinflammation-behavior-in-parkinsons-mice/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 12 Jan 2026 10:41:20 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[davranışsal iyileşme** **Açıklama:** 1. **delphinidin:** Çalışmanın ana odağı olan bileşik. 2. **Parkinson hastalığı:** Araştırmanın hedef aldığı temel]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **delphinidin]]></category>
		<category><![CDATA[İşte 5 uygun etiket: `delphinidin]]></category>
		<category><![CDATA[mouse model]]></category>
		<category><![CDATA[Neuroinflammation]]></category>
		<category><![CDATA[Nöroenflamasyon]]></category>
		<category><![CDATA[nörokoruma]]></category>
		<category><![CDATA[Parkinson hastalığı]]></category>
		<category><![CDATA[Parkinson’s disease]]></category>
		<guid isPermaLink="false">https://bioengineer.org/delphinidin-eases-neuroinflammation-behavior-in-parkinsons-mice/</guid>

					<description><![CDATA[In a groundbreaking study set to redefine the therapeutic landscape for Parkinson’s disease (PD), researchers have unveiled the potent neuroprotective effects of delphinidin, a naturally occurring anthocyanidin found mainly in pigmented fruits and vegetables. This new research, recently published in npj Parkinson’s Disease, elucidates how delphinidin modulates neuroinflammation and alleviates behavioral deficits in a Parkinson’s [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316050</post-id>	</item>
		<item>
		<title>Low Muscle Mass, Orthostatic Hypotension Linked in Parkinson’s</title>
		<link>https://bioengineer.org/low-muscle-mass-orthostatic-hypotension-linked-in-parkinsons/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 17:15:00 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[İşte bu yazı için 5 uygun etiket (virgülle ayrılmış): **Sarkopeni]]></category>
		<category><![CDATA[Nörodejeneratif bozukluklar** **Açıklama:** 1. **Sarkopeni:** Makalenin temel konusu olan düşük kas]]></category>
		<category><![CDATA[Ortostatik hipotansiyon]]></category>
		<category><![CDATA[Otonomik disfonksiyon]]></category>
		<category><![CDATA[Parkinson hastalığı]]></category>
		<guid isPermaLink="false">https://bioengineer.org/low-muscle-mass-orthostatic-hypotension-linked-in-parkinsons/</guid>

					<description><![CDATA[In a groundbreaking study published in the journal npj Parkinson’s Disease in 2026, researchers have unveiled critical insights into the prevalence of low muscle mass among patients suffering from Parkinson’s disease (PD), and its troubling association with orthostatic hypotension and related clinical symptoms. This investigation sheds light on an unexplored intersection between muscle physiology and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315384</post-id>	</item>
		<item>
		<title>Video AI Predicts Parkinson’s Deep Brain Therapy Results</title>
		<link>https://bioengineer.org/video-ai-predicts-parkinsons-deep-brain-therapy-results/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 15:07:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Derin beyin stimülasyonu]]></category>
		<category><![CDATA[İşte 5 uygun etiket (sadece virgülle ayrılmış): **Makine öğrenimi]]></category>
		<category><![CDATA[Parkinson hastalığı]]></category>
		<category><![CDATA[Tahminsel model** **Kısa açıklama:** * **Makine öğrenimi:** Tekniğin temelini oluşturuyor. * **Parkinson hastal]]></category>
		<category><![CDATA[Video analizi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/video-ai-predicts-parkinsons-deep-brain-therapy-results/</guid>

					<description><![CDATA[In a groundbreaking stride toward personalized treatment for Parkinson’s disease, researchers have unveiled an innovative video-based machine learning framework capable of predicting the therapeutic outcomes of deep brain stimulation (DBS) with remarkable accuracy. This pioneering approach, introduced by Hu, Zhang, Yin, and colleagues in a forthcoming publication in npj Parkinson’s Disease, harnesses advanced video analytics [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315296</post-id>	</item>
		<item>
		<title>Uric Acid’s Protective Role in Parkinson’s Reviewed</title>
		<link>https://bioengineer.org/uric-acids-protective-role-in-parkinsons-reviewed/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 19 Nov 2025 15:38:11 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[alfa-sinüklein **Açıklama:** 1. **Parkinson hastalığı:** Makalenin ana konusu Parkinson hastalığıdır (PD). 2. **Ürik asit:** Makalenin odak noktası ürik asidin (UA) rolüdür]]></category>
		<category><![CDATA[nöroproteksiyon]]></category>
		<category><![CDATA[Parkinson hastalığı]]></category>
		<category><![CDATA[Terapötik Hedefler]]></category>
		<category><![CDATA[ürik asit]]></category>
		<guid isPermaLink="false">https://bioengineer.org/uric-acids-protective-role-in-parkinsons-reviewed/</guid>

					<description><![CDATA[In recent years, a growing body of research has illuminated the intricate neuroprotective roles uric acid (UA) may play in neurological disorders, particularly Parkinson’s disease (PD). A comprehensive review by Liu and Reynolds, published in npj Parkinson’s Disease, synthesizes current experimental findings, unveiling molecular mechanisms through which UA exerts its protective influence in cellular and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">298769</post-id>	</item>
	</channel>
</rss>
